Kingfisher Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-8,283
Closed -$2.13M 149
2014
Q4
$2.13M Buy
8,283
+319
+4% +$79.7K 1.09% 23
2014
Q3
$1.92M Sell
7,964
-56
-0.7% -$12.5K 1.03% 23
2014
Q2
$1.79M Sell
8,020
-461
-5% -$95.5K 0.93% 34
2014
Q1
$1.75M Buy
8,481
+23
+0.3% +$4.56K 0.92% 38
2013
Q4
$1.42M Sell
8,458
-6,152
-42% -$962K 0.76% 50
2013
Q3
$2.1M Sell
14,610
-438
-3% -$58.3K 1.07% 25
2013
Q2
$1.9M Buy
+15,048
New +$1.7M 1.04% 28

Other funds holding AGN

Kingfisher Capital's AGN Position: Q1 2015 in Review

Kingfisher Capital sold out of Allergan plc (AGN) in Q1 2015, closing a stake of 8,283 shares — an estimated $2.13M sold.

Kingfisher Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.13M in Q4 2014. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Kingfisher Capital reported no remaining Allergan plc position as of Q1 2015 after selling out during the quarter.
  • Kingfisher Capital sold 8,283 Allergan plc shares in Q1 2015, an estimated $2.13M.
  • Kingfisher Capital first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • Kingfisher Capital's Allergan plc position peaked at $2.13M in Q4 2014.
  • 1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Kingfisher Capital's 13F filing for Q1 2015, filed 14 May 2015.